u 69593 has been researched along with amphetamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inderbitzin, S; Lauber, ME; Lichtensteiger, W; Schlumpf, M | 1 |
Partridge, B; Schenk, S; Shippenberg, TS | 1 |
Gray, AM; McGinty, JF; Rawls, SM; Shippenberg, TS | 1 |
De Vries, TJ; Schoffelmeer, AN; Vanderschuren, LJ; Wardeh, G | 1 |
Partridge, B; Schenk, S | 1 |
McGinty, JF; Tzaferis, JA | 1 |
He, L; Hjelmstad, GO; Whistler, JL; Xia, YF | 1 |
Andrés, ME; Fuentealba, JA; Gysling, K | 1 |
8 other study(ies) available for u 69593 and amphetamine
Article | Year |
---|---|
Amphetamine-induced preprodynorphin mRNA expression and kappa-opioid receptor binding in basal ganglia of adult rats after prenatal exposure to diazepam.
Topics: Age Factors; Amphetamine; Analgesics; Animals; Basal Ganglia; Benzeneacetamides; Binding, Competitive; Diazepam; Dynorphins; Female; GABA Modulators; Gene Expression; In Situ Hybridization; Male; Pregnancy; Prenatal Exposure Delayed Effects; Protein Precursors; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa; RNA, Messenger; Sympathomimetics; Tritium | 1997 |
U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking.
Topics: Amphetamine; Animals; Behavior, Addictive; Benzeneacetamides; Cocaine-Related Disorders; Dopamine Antagonists; Dopamine Uptake Inhibitors; Flupenthixol; Male; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Self Administration | 1999 |
The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum.
Topics: Amphetamine; Animals; Behavior, Animal; Benzeneacetamides; Calcium; Dopamine; Glutamic Acid; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Neostriatum; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1999 |
Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amphetamine; Analgesics; Animals; Benzeneacetamides; Benzomorphans; Central Nervous System Stimulants; Cocaine; Male; Motor Activity; Psychomotor Agitation; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 2000 |
Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behavior.
Topics: Amphetamine; Analgesics; Animals; Behavior, Addictive; Benzeneacetamides; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Self Administration | 2001 |
Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum.
Topics: Amphetamine; Analgesics; Animals; Behavior, Animal; Benzeneacetamides; Central Nervous System Stimulants; Corpus Striatum; Dynorphins; Enkephalins; Gene Expression; In Situ Hybridization; Male; Neuropeptides; Protein Precursors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Stimulation, Chemical; Substance P | 2001 |
Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens.
Topics: Amphetamine; Analgesics, Opioid; Analysis of Variance; Animals; Benzeneacetamides; Central Nervous System Stimulants; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dynorphins; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Male; Narcotic Antagonists; Nucleus Accumbens; Patch-Clamp Techniques; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2008 |
Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
Topics: Amphetamine; Analgesics; Analysis of Variance; Animals; Behavior, Animal; Benzeneacetamides; Central Nervous System Stimulants; Drug Administration Schedule; Drug Synergism; Male; Microdialysis; Motor Activity; Pyrrolidines; Rats; Rats, Sprague-Dawley; Time Factors | 2007 |